Efficacity of Idelalisib and Obinutuzumab in Patient With Relapsed Refractory Waldenstrom's Macroglobulinemia
Clinical trial NCT02962401 · COMPLETED
Trial details
- NCT number
- NCT02962401
- Sponsor
- French Innovative Leukemia Organisation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-07
- Primary completion
- 2020-08-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.